Relationship of epidermal growth factor binding capacity to histopathologic features and prognosis in human renal cell carcinoma

Invasion and Metastasis

Volumn 17, Issue 2, 1998, Pages 94-100

  Sakamoto, Shu Ichi ^a   Kitahara, Satoshi ^a   Sumi, Shuhei ^a   Horiuchi, Susumu ^a   Yoshida, Ken Ichiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Epidermal growth factor binding; Histopathologic features; Prognosis; Renal cell carcinoma; Scatchard analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; SCATCHARD PLOT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0345487541     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Medeiros LJ, Gelb AB, Weiss LM: Renal cell carcinoma: Prognostic significance of morphologic parameters in 121 cases. Cancer 1988;61: 1639-1651.
2. Grignon DJ, El-naggar A, Green LK, Ayala AG, Ro JY, Swanson DA, Troncoso P, McLemore D, Giacco GG, Guinee VF: DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma. Cancer 1989;63:1161-1165.
3. Strohmeyer T, Ackermann R: Classic and modern prognostic indicators in renal cell carcinoma. Urol Int 1991;47:203-212.
4. Lanigan D, McLean PA, Murphy DM, Donovan MG, Curran B, Leader M: Ploidy and prognosis in renal carcinoma. Br J Urol 1993;71: 21-24.
5. Takashi M, Nakano Y, Sakata T, Miyake K, Hamajima N: Multivariate evaluation of prognostic determinants for renal cell carcinoma. Urol Int 1993;50:6-12.
6. Stoscheck CM, King LE Jr: Role of epidermal growth factor in carcinogenesis. Cancer Res 1986;46:1030-1037.
7. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factor α and β and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-712.
8. Carpenter G: Receptor for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987;56:881-914.
9. Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 1984; 44:3448-3453.
10. Berger MS; Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE, Harris AL, Waterfield MD: Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 1987;56:533-537.
11. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL: The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 1990;65:1619-1625.
12. Ozawa S, Ueda M, Ando N, Abe O, Shimizu N: High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas. Int J Cancer 1987;39:333-337.
13. Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL: Epidermal growth factor recpetors in non-small cell lung cancer. Br J Cancer 1987; 55:513-516.
14. Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, Tahara E: Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 1988;48:137-141.
15. Neal DE, Bennett MK, Hall RR, Marsh C, Abel PD, Sainsbury JRC, Harris AL: Epidermal-growth-factor receptors in human bladder cancer: Comparison of invasive and superficial tumors. Lancet 1985;i:366-368.
16. Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA: The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: A review of 5,232 patients. Endocr Rev 1992;13:3-16.
17. Rail LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan JP: Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 1985; 313:228-231.
18. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WDW, Fair WR: Expression of transforming growth factor a and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 1989;49:3407-3411.
19. Gomella LG, Sargent ER, Wade TP, Anglard P, Linehan WM, Kasid A: Expression of transforming growth factor a in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma. Cancer Res 1989;49:6972-6975.
20. Yoshida KI, Tosaka A, Takeuchi SI, Kobayashi N: Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 1994; 73:1913-1918.
21. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6: 655-663.
22. Yoshida KI, Tosaka A: Epidermal growth factor binding by membranes of human renal cell carcinomas: Establishment of an epidermal growth factor receptor assay for clinical use. Int J Urol 1994;1:319-323.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
24. Murphy GP, Mostofi FK: The significance of cytoplasmic granularity in the prognosis of renal cell carcinoma. J Urol 1965;94:48-54.
25. Amtrup F, Hansen JB, Thybo E: Prognosis in renal carcinoma evaluated from histological criteria. Scand J Urol Nephrol 1974;8:198-202.
26. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF: Diagnosis and management of renal cell carcinoma: A clinical and pathologic study of 309 cases. Cancer 1971;28:1165-1177.
27. Tomera KM, Farrow GM, Lieber MM: Well differentiated (grade 1) clear cell renal carcinoma. J Urol 1983;129:933-937.
28. Scheeter DJ, Silverman ML: Papillary adenocarcinoma of the kidney: An analysis of 35 cases: Does histopathologcy influence prognosis? Lab Invest 1985;52:58A.
29. Uhlman DL, Nguyen P, Manivel JC, Zhang G, Hagen K, Fraley E, Aeppli D, Niehans GA: Epidermal growth factor receptor and transforming growth factor α expression in papillary and nonpapillary renal cell carcinoma. Correlation with metastatic behavior and prognosis. Clin Cancer Res 1995;1:913-920.
30. Yoshida KI, Hosoya Y, Sumin S, Honda M, Moriguchi H, Yano M, Ueda Y: Studies of the expression of epidermal growth factor receptor in human renal cell carcinoma; a comparison of immunohistochemical method versus ligand binding assay. Oncology 1997;54:220-225.
31. Ljungberg B, Gafvels M, Damber JE: Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy. Urol Res 1994;22: 305-308.